Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125745342 | 12574534 | 2 | F | 2015 | 20160802 | 20160720 | 20160808 | EXP | CA-GLAXOSMITHKLINE-CA2015GSK016839 | GLAXOSMITHKLINE | 74.09 | YR | F | Y | 52.00000 | KG | 20160808 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125745342 | 12574534 | 1 | SS | Volibris | AMBRISENTAN | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
125745342 | 12574534 | 2 | SS | Ampicillin | AMPICILLIN | 1 | UNK | U | 0 | SUPPOSITORY | |||||||||
125745342 | 12574534 | 3 | PS | Salbutamol | ALBUTEROL | 1 | UNK | U | 20983 | ||||||||||
125745342 | 12574534 | 4 | SS | NOVO-SALBUTAMOL HFA | ALBUTEROL | 1 | 2 PUFF(S), UNK | 0 | 2 | DF | |||||||||
125745342 | 12574534 | 5 | C | DICETEL | PINAVERIUM BROMIDE | 1 | UNK | U | 0 | ||||||||||
125745342 | 12574534 | 6 | C | SALBUTAMOL | ALBUTEROL | 1 | UNK | U | 0 | ||||||||||
125745342 | 12574534 | 7 | C | TECTA | PANTOPRAZOLE MAGNESIUM | 1 | UNK | U | 0 | ||||||||||
125745342 | 12574534 | 8 | C | ZOPLICONE | ZOPICLONE | 1 | U | 0 | |||||||||||
125745342 | 12574534 | 9 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | U | 0 | |||||||||||
125745342 | 12574534 | 10 | C | APO-MOMETASONE | MOMETASONE FUROATE | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125745342 | 12574534 | 1 | Pulmonary arterial hypertension |
125745342 | 12574534 | 2 | Dental operation |
125745342 | 12574534 | 3 | Product used for unknown indication |
125745342 | 12574534 | 4 | Product used for unknown indication |
125745342 | 12574534 | 5 | Product used for unknown indication |
125745342 | 12574534 | 6 | Product used for unknown indication |
125745342 | 12574534 | 7 | Product used for unknown indication |
125745342 | 12574534 | 8 | Product used for unknown indication |
125745342 | 12574534 | 9 | Product used for unknown indication |
125745342 | 12574534 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125745342 | 12574534 | HO |
125745342 | 12574534 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125745342 | 12574534 | Abdominal discomfort | |
125745342 | 12574534 | Abdominal pain upper | |
125745342 | 12574534 | Asthenia | |
125745342 | 12574534 | Chest pain | |
125745342 | 12574534 | Cough | |
125745342 | 12574534 | Drug interaction | |
125745342 | 12574534 | Drug intolerance | |
125745342 | 12574534 | Enamel anomaly | |
125745342 | 12574534 | Fatigue | |
125745342 | 12574534 | Gastric antral vascular ectasia | |
125745342 | 12574534 | Gingival recession | |
125745342 | 12574534 | Headache | |
125745342 | 12574534 | Heart rate increased | |
125745342 | 12574534 | Helminthic infection | |
125745342 | 12574534 | Influenza | |
125745342 | 12574534 | Pain | |
125745342 | 12574534 | Product use issue | |
125745342 | 12574534 | Rectal haemorrhage | |
125745342 | 12574534 | Sinus congestion | |
125745342 | 12574534 | Sleep disorder | |
125745342 | 12574534 | Tooth disorder | |
125745342 | 12574534 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125745342 | 12574534 | 1 | 20140510 | 0 | ||
125745342 | 12574534 | 2 | 2015 | 0 |